{"id":"https://openalex.org/W2353626236","doi":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","title":"Novel Platinum Derivatives Loaded Targeted Nanoemulsions for Improved Potency [30Q]","display_name":"Novel Platinum Derivatives Loaded Targeted Nanoemulsions for Improved Potency [30Q]","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2353626236","doi":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","mag":"2353626236"},"language":"en","primary_location":{"id":"doi:10.1097/01.aog.0000483588.17325.c9","doi":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","pdf_url":null,"source":{"id":"https://openalex.org/S139838620","display_name":"Obstetrics and Gynecology","issn_l":"0029-7844","issn":["0029-7844","1873-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obstetrics & Gynecology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076461298","display_name":"Niravkumar R. Patel","orcid":"https://orcid.org/0000-0001-7669-9071","observed_orcids":["https://orcid.org/0000-0001-7669-9071"]},"institutions":[{"id":"https://openalex.org/I4210149090","display_name":"Nemucore Medical Innovations (United States)","ror":"https://ror.org/04es4vf69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149090"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niravkumar Patel","raw_affiliation_strings":["Nemucore Medical Innovations, Worcester, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nemucore Medical Innovations, Worcester, MA","institution_ids":["https://openalex.org/I4210149090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077247752","display_name":"Aleksandr Piroyan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149090","display_name":"Nemucore Medical Innovations (United States)","ror":"https://ror.org/04es4vf69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149090"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleksandr Piroyan","raw_affiliation_strings":["Nemucore Medical Innovations, Worcester, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nemucore Medical Innovations, Worcester, MA","institution_ids":["https://openalex.org/I4210149090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113481295","display_name":"Barbara J. Davis","orcid":"https://orcid.org/0000-0002-1144-3216","observed_orcids":["https://orcid.org/0000-0002-1144-3216"]},"institutions":[{"id":"https://openalex.org/I4210149090","display_name":"Nemucore Medical Innovations (United States)","ror":"https://ror.org/04es4vf69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149090"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Davis","raw_affiliation_strings":["Nemucore Medical Innovations, Worcester, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nemucore Medical Innovations, Worcester, MA","institution_ids":["https://openalex.org/I4210149090"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033060435","display_name":"Timothy P. Coleman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149090","display_name":"Nemucore Medical Innovations (United States)","ror":"https://ror.org/04es4vf69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149090"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Coleman","raw_affiliation_strings":["Nemucore Medical Innovations, Worcester, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nemucore Medical Innovations, Worcester, MA","institution_ids":["https://openalex.org/I4210149090"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210149090"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"127","issue":"Supplement 1","first_page":"147S","last_page":"147S"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.08229999989271164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10411","display_name":"Proteins in Food Systems","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platinum-derivatives","display_name":"platinum derivatives","score":0.7099999785423279},{"id":"https://openalex.org/keywords/nanoemulsions","display_name":"nanoemulsions","score":0.9480000138282776},{"id":"https://openalex.org/keywords/folate-targeting","display_name":"folate targeting","score":0.7979999780654907},{"id":"https://openalex.org/keywords/ceramide","display_name":"ceramide","score":0.8700000047683716},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5130000114440918},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7440000176429749},{"id":"https://openalex.org/keywords/circulation-time","display_name":"circulation time","score":0.6520000100135803},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.796999990940094},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6100000143051147},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.8110048174858093},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6788188815116882},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.566006600856781},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.546464204788208},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.5244845747947693},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5202202200889587},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49692991375923157},{"id":"https://openalex.org/C518104683","wikidata":"https://www.wikidata.org/wiki/Q880","display_name":"Platinum","level":3,"score":0.43726375699043274},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.4274539053440094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41318368911743164},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2762395739555359},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.24157708883285522},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.23864632844924927},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.14578214287757874},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.08660948276519775},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.aog.0000483588.17325.c9","doi":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aog.0000483588.17325.c9","pdf_url":null,"source":{"id":"https://openalex.org/S139838620","display_name":"Obstetrics and Gynecology","issn_l":"0029-7844","issn":["0029-7844","1873-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obstetrics & Gynecology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2359751755","https://openalex.org/W2006804334","https://openalex.org/W2091945030","https://openalex.org/W2180810611","https://openalex.org/W2181136653","https://openalex.org/W4416794829","https://openalex.org/W3160380456","https://openalex.org/W4311796447","https://openalex.org/W4211237467","https://openalex.org/W2408210747"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Platinum":[1,207],"based":[2],"chemotherapy,":[3],"introduced":[4],"four":[5],"decades":[6],"ago,":[7],"is":[8,171],"widely":[9],"used":[10,172],"against":[11,234],"many":[12],"types":[13],"of":[14,78,145,197,201,230],"cancers.":[15],"It":[16],"faces":[17],"challenges":[18,38],"such":[19],"as":[20,39,89,91,221],"dose":[21],"limiting":[22],"toxicities,":[23],"cumulative":[24],"side":[25],"effects":[26],"and":[27,53,68,86,105,110,138,168,216],"multidrug":[28],"resistance.":[29],"Nanoemulsions":[30,97],"have":[31],"shown":[32],"tremendous":[33],"potential":[34],"in":[35,74,125,142,177,204,214],"overcoming":[36],"these":[37],"it":[40],"can":[41,71],"be":[42,72],"designed":[43],"to":[44,48,54,173,193],"improve":[45,49,55],"circulation":[46,186],"time,":[47],"tumor":[50],"tissue":[51],"uptake,":[52],"cellular":[56],"uptake":[57],"by":[58,84,118],"surface":[59],"modification.":[60],"Three":[61],"novel":[62],"difatty":[63],"acid":[64,155],"platinums,":[65],"dimyrisplatin,":[66],"diplamiplatin,":[67],"distearyplatin,":[69],"those":[70],"sequestered":[73],"the":[75,143,151,153,157,160,165,175],"oil":[76],"core":[77],"a":[79],"nanoemulsion,":[80],"were":[81,98,116,123,211],"synthesized,":[82],"characterized":[83,106],"NMR":[85],"elemental":[87],"analysis":[88],"well":[90],"evaluated":[92],"for":[93,107,188],"their":[94],"potency.":[95],"METHODS:":[96],"synthesized":[99],"using":[100],"high":[101],"shear":[102],"microfluidization":[103],"process":[104],"size,":[108],"zeta":[109],"loading":[111],"efficiency.":[112],"In":[113],"vitro":[114,178,215],"cytotoxicities":[115],"measured":[117],"MTT":[119],"assay.":[120],"Pharmacokinetic":[121],"profiles":[122],"studied":[124],"Balb/c":[126],"mice.":[127],"RESULTS:":[128],"NEs":[129],"system":[130],"loaded":[131,209,232],"with":[132],"platinum":[133],"variants":[134,191],"are":[135],"highly":[136],"stable":[137],"had":[139],"size":[140],"distribution":[141],"range":[144],"100\u2013150":[146],"nm.":[147],"Cytotoxicity":[148],"data":[149,225],"indicates":[150],"longer":[152],"fatty":[154],"chains,":[156],"less":[158],"potent":[159,213],"nanoemulsions.":[161,205],"However,":[162],"when":[163],"C6-Ceramide,":[164],"apoptosis":[166],"enhancer,":[167],"folate":[169],"targeting":[170],"functionalize,":[174],"nanoemulsions":[176,210,233],"potency":[179],"significantly":[180],"increases.":[181],"Upon":[182],"examining":[183],"pK":[184],"data,":[185],"time":[187,200],"all":[189],"three":[190],"appeared":[192],"remain":[194],"identical,":[195],"indication":[196],"unaltered":[198],"residence":[199],"lipidated":[202],"platinums":[203],"CONCLUSION:":[206],"dimyrisplatin":[208,231],"most":[212],"demonstrated":[217],"identical":[218],"pharmacokinetic":[219],"profile":[220],"other":[222],"variants.":[223],"These":[224],"warrants":[226],"further":[227],"clinical":[228],"development":[229],"MDR":[235],"tumors.":[236]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}